Oxaliplatin and Bolus-Modulated 5-Fluorouracil as a Second-Line Treatment for Advanced Pancreatic Cancer: Can Bolus Regimens Replace FOLFOX When Considered for Second Line?
Table 2
Patients with grade 3 or 4 toxicity by the NCI Common Toxicity Criteria version 3.0.